Journal · Pharmacology · Updated 22 November 2026
Current Pharmacology Reports
Read Current Pharmacology Reports articles on DeepDyve. No university library needed.
Current Pharmacology Reports has published since 2015 and covers reviews across pharmacology, with recent papers on subcutaneous antibody-drug conjugates, plant metabolomics in drug discovery and chitosan-based diabetes treatments. Springer Nature publishes it. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Current Pharmacology Reports at a glance
- Full title
- Current Pharmacology Reports
- Abbreviation (NLM)
- Curr Pharmacol Rep
- Publisher
- Springer Nature
- ISSN (online only)
- 2198-641X
- First published
- 2015
- Access model
- Hybrid (17% free to read in 2026)
Ways to access Current Pharmacology Reports
17% of the articles Current Pharmacology Reports published from January 1 to November 20, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 17% of Current Pharmacology Reports articles published from January 1 to November 20, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Current Pharmacology Reports. Check its journal list and whether it offers remote access.
- DeepDyve. Read Current Pharmacology Reports articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Current Pharmacology Reports’ 2025 Journal Impact Factor is 1.8.
1.8
Journal Impact Factor (2025)
14 days
Median time to first decision
Source: journal metrics on the Current Pharmacology Reports homepage (Springer Nature), checked November 22, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Current Pharmacology Reports research worth reading
Published January to May 2026. Summaries describe what the authors report.
-
Subcutaneous Administration of Antibody-drug Conjugates
The authors review subcutaneous dosing of antibody-drug conjugates, noting early studies show it is feasible with predictable pharmacokinetics, and discuss the formulation, hyaluronidase, linker and modeling advances that support it, with stable linkers and payloads key to limiting injection-site toxicity.
Yaseen et al. · Current Pharmacology Reports, published online January 23, 2026 · DOI 10.1007/s40495-026-00442-5
-
Plant Metabolomics in Natural Product Drug Discovery: Emerging Approaches, Challenges, and Translational Potential
The authors review how NMR, mass spectrometry and computational tools such as machine learning help plant metabolomics find drugs among natural products, and note persistent problems with reproducibility, database coverage and regulation.
Meshram et al. · Current Pharmacology Reports, published online March 31, 2026 · DOI 10.1007/s40495-026-00452-3
-
Exploring the Role of Medicinal Plants in Breast and Oral Cancer Treatment- A Review
The authors review medicinal plants in oral and breast cancer, describing how compounds such as curcumin, resveratrol, quercetin, EGCG and berberine act on cancer cells through cell cycle arrest, anti-angiogenesis and other mechanisms.
M et al. · Current Pharmacology Reports, published online May 13, 2026 · DOI 10.1007/s40495-026-00465-y
-
A comprehensive Review on Ethnobotany, Nutraceuticals and Cosmetic Potentials of Cinnamon (Cinnamomum Schaeff.)
The authors review the traditional, nutraceutical and cosmetic uses of cinnamon species and describe antifungal, antibacterial, anti-inflammatory, anticancer, antioxidant and wound-healing activities found in studies, with many highlighting C. verum and C. cassia.
Varghese et al. · Current Pharmacology Reports, published online March 9, 2026 · DOI 10.1007/s40495-026-00446-1
-
A Review on Multi-functional Chitosan Derivatives for Diabetes Management: Mucoadhesive Drug Delivery and Diabetic Wound-healing Applications
The authors review chitosan derivatives in diabetes care, covering delivery of insulin, metformin and phytochemicals by buccal, oral and transdermal routes as well as wound-healing dressings, and note scalability, regulatory and long-term safety hurdles.
Karthick et al. · Current Pharmacology Reports, published online May 7, 2026 · DOI 10.1007/s40495-026-00464-z
Related journals
Questions about Current Pharmacology Reports
How can I read Current Pharmacology Reports articles without a subscription?
17% of Current Pharmacology Reports articles published from January 1 to November 20, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Current Pharmacology Reports articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Current Pharmacology Reports?
Current Pharmacology Reports’ NLM (PubMed) abbreviation is Curr Pharmacol Rep.
What is the ISSN of Current Pharmacology Reports?
Current Pharmacology Reports is published online only; its ISSN is 2198-641X.
What is the impact factor of Current Pharmacology Reports?
Current Pharmacology Reports’ Journal Impact Factor is 1.8 (2025), according to Springer Nature’s published metrics.
Is Current Pharmacology Reports open access?
Current Pharmacology Reports is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 20, 2026, 7 of 42 Current Pharmacology Reports articles (17%) carry a Creative Commons license, per Crossref.
Current Pharmacology Reports articles on DeepDyve are licensed from Springer Nature. Journal facts as of 22 November 2026.
Start reading Current Pharmacology Reports today
One month free, then less than $2 a day. Current Pharmacology Reports, plus millions of articles from thousands of journals.





